These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29209175)

  • 1. Editorial: Biology of Brain Disorders.
    Tropea D; Harkin A
    Front Cell Neurosci; 2017; 11():366. PubMed ID: 29209175
    [No Abstract]   [Full Text] [Related]  

  • 2. Putamen gray matter volumes in neuropsychiatric and neurodegenerative disorders.
    Luo X; Mao Q; Shi J; Wang X; Li CR
    World J Psychiatry Ment Health Res; 2019; 3(1):. PubMed ID: 31328186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Contribution of Translational Animal Models to the Systems Biology of Neurodegenerative Disorders.
    Mohamed WMY; Salama MM; Batsh MME; Goh EL
    Front Physiol; 2020; 11():775. PubMed ID: 32848812
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroimaging signature of neuropsychiatric disorders.
    Worbe Y
    Curr Opin Neurol; 2015 Aug; 28(4):358-64. PubMed ID: 26110796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Biomarkers in Neuropsychiatric Disorders Based on Systems Biology and Epigenetics.
    Peedicayil J
    Front Genet; 2019; 10():985. PubMed ID: 31681422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial commentary: "What does immunology have to do with brain development and neuropsychiatric disorders?".
    Leckman JF; Vaccarino FM
    Brain Res; 2015 Aug; 1617():1-6. PubMed ID: 25283746
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk for broad-spectrum neuropsychiatric disorders after mild traumatic brain injury in a cohort of US Air Force personnel.
    Miller SC; Whitehead CR; Otte CN; Wells TS; Webb TS; Gore RK; Maynard C
    Occup Environ Med; 2015 Aug; 72(8):560-6. PubMed ID: 25896331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Non-motor Symptoms in Primary Motor Neurological Disorders: From Molecular Pathways to Clinical and Therapeutic Implications.
    Christidi F; De Micco R; Ehgoetz Martens KA; Moglia C; Trojsi F
    Front Neurosci; 2019; 13():1296. PubMed ID: 31849599
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of hyperbaric oxygen treatment of neuropsychiatric disorders following traumatic brain injury.
    Shi XY; Tang ZQ; Sun D; He XJ
    Chin Med J (Engl); 2006 Dec; 119(23):1978-82. PubMed ID: 17199942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The translocator protein (18kDa) and its role in neuropsychiatric disorders.
    Barichello T; Simões LR; Collodel A; Giridharan VV; Dal-Pizzol F; Macedo D; Quevedo J
    Neurosci Biobehav Rev; 2017 Dec; 83():183-199. PubMed ID: 29054730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNAs in early brain development and their influence and clinical significance in neuropsychiatric disorders.
    Zhuo CJ; Hou WH; Jiang DG; Tian HJ; Wang LN; Jia F; Zhou CH; Zhu JJ
    Neural Regen Res; 2020 May; 15(5):817-823. PubMed ID: 31719241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: When Physics Meets Biology; Biomechanics and Biology of Traumatic Brain Injury.
    Agoston DV; Sköld MK
    Front Neurol; 2016; 7():91. PubMed ID: 27379010
    [No Abstract]   [Full Text] [Related]  

  • 13. mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.
    Ryskalin L; Limanaqi F; Frati A; Busceti CL; Fornai F
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychiatric Predictors of Post-Injury Headache After Mild-Moderate Traumatic Brain Injury in Veterans.
    Bomyea J; Lang AJ; Delano-Wood L; Jak A; Hanson KL; Sorg S; Clark AL; Schiehser DM
    Headache; 2016 Apr; 56(4):699-710. PubMed ID: 27028095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron in brain function and neurodegenerative disorders. Editorial.
    Mandel S; Grünblatt E; Riederer P
    J Neural Transm (Vienna); 2011 Mar; 118(3):299-300. PubMed ID: 21400002
    [No Abstract]   [Full Text] [Related]  

  • 16. Brain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin.
    Theoharides TC; Stewart JM; Hatziagelaki E; Kolaitis G
    Front Neurosci; 2015; 9():225. PubMed ID: 26190965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor type 1 and its relation with neuropsychiatric disorders.
    Zegarra-Valdivia JA
    Medwave; 2017 Aug; 17(7):e7031. PubMed ID: 28863129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric Syndromes in Neurodegenerative Disease: Frequency and Signficance.
    Cummings JL; Diaz C; Levy M; Binetti G; Litvan I
    Semin Clin Neuropsychiatry; 1996 Oct; 1(4):241-247. PubMed ID: 10320427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain CB₂ Receptors: Implications for Neuropsychiatric Disorders.
    Roche M; Finn DP
    Pharmaceuticals (Basel); 2010 Aug; 3(8):2517-2553. PubMed ID: 27713365
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.